Trust your Alzheimer’s disease trial to the scientific, medical, and operational experts at Worldwide Clinical Trials’ who have been leading Alzheimer’s disease (AD) research since the advent of cholinesterase inhibitors as a cognitive therapeutic in the late 1970s. It’s been a long road on the way to finding a cure for Alzheimer’s disease and related dementias. And we’re not about to give up now.
Our 40 year tradition of clinical trial excellence is centered on Alzheimer’s Disease. Unparalleled experience in this indication (including related dementias) enables us to thoroughly understand the complexities in evaluating patients with various phenotypes, and to implement specific study design features in Alzheimer’s disease clinical trials that mitigate risks and challenges.
Are you also engaged in the global effort against Alzheimer’s disease and other dementias?
Let us help you.